Need for improvements in the surveillance and management of chronic viral hepatitis in HIV patients followed in a Danish outpatient clinic

References

• Lohse N, Hansen AB, Jensen-Fangel S, Kronborg G, Kvinesdal B, Pedersen C, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005;37:338–43.
   PubMed Web of Science ®Google Scholar
• Omland LH, Weis N, Skinhøj P, Laursen AL, Christensen PB, Nielsen HI, et al. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study. HIV Med 2008;9:300–6.
   PubMed Web of Science ®Google Scholar
• Lohse N, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Comorbidity acquired before HIV diagnosis and mortality in persons infected and uninfected with HIV: a Danish population-based cohort study. J Acquir Immune Defic Syndr 2011;57:334–9.
   PubMed Web of Science ®Google Scholar
• Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008;9:82–8.
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4):1–207.
   Google Scholar
• Hoover KW, Butler M, Workowski KA, Follansbee S, Gratzer B, Hare CB, et al. Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis 2012;39:349–53.
   PubMed Web of Science ®Google Scholar
• Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54:1–23.
   PubMedGoogle Scholar
• Guidelines Version 7.0 – October 2013. European AIDS Clinical Society; 2013. Available at: http://www.eacsociety.org/Portals/0/Guidelines_Online_131014.pdf (accessed 9 March 2014).
   Google Scholar
• Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA, et al. Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2008;47:50–5.
   PubMed Web of Science ®Google Scholar
• Sundhedsstyrelsen. Vejledning om forebyggelse mod viral hepatitis –Juni 2002. Denmark: Sundhedsstyrelsen; 2002.
   Google Scholar
• Sundhedsstyrelsen. Vejledning om HIV (human immundefekt virus), hepatitis B og C virus. Denmark: Sundhedsstyrelsen; 2013.
   Google Scholar
• Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003;188:571–7.
   PubMed Web of Science ®Google Scholar
• Landrum ML, Hullsiek KH, Chun HM, Crum-Cianflone NF, Ganesan A, Weintrob AC, et al. The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis. Am J Epidemiol 2011;173:84–93.
   Google Scholar
• Kim HN, Harrington RD, Rompaey SE, Kitahata MM. Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons. Int J STD AIDS 2008;19:600–4.
   PubMed Web of Science ®Google Scholar
• Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, et al. Vaccination against hepatitis B with 4 double doses increases response rates and antibodies titers in HIV-infected adults. Vaccine 2012;30:5973–7.
   PubMed Web of Science ®Google Scholar
• Powis JE, Raboud J, Ostrowski M, Loutfy MR, Kovacs C, Walmsley SL. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?J Infect Dis 2012;205:1534–8.
   PubMed Web of Science ®Google Scholar
• Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005;19:593–601.
   PubMed Web of Science ®Google Scholar
• Spradling PR, Richardson JT, Buchacz K, Moorman AC, Brooks JT; the HIV Outpatient Study (HOPS) Investigators. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007. J Viral Hepat 2010;17:879–86.
   PubMed Web of Science ®Google Scholar
• Gatanaga H, Hayashida T, Tanuma J, Oka S. Prophylactic effect of antiretroviral therapy on hepatitis B virus infection. Clin Infect Dis 2013;56:1812–9.
   PubMed Web of Science ®Google Scholar
• Vogel M, Boesecke C, Rockstroh JK. Acute hepatitis C infection in HIV-positive patients. Curr Opin Infect Dis 2011;24:1–6.
   PubMed Web of Science ®Google Scholar
• Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001–2009. Euro Surveill 2010;15:19673.
   PubMedGoogle Scholar
• Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007;44:577–83.
   PubMed Web of Science ®Google Scholar
• Thomson EC, Nastouli E, Main J, Karayiannis P, Eliahoo J, Muir D, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009;23: 89–93.
   PubMed Web of Science ®Google Scholar